Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.

Gianluca Aguiari, Manuela Banzi, Stefania Gessi, Yiqiang Cai, Emanuela Zeggio, Elisa Manzati, Roberta Piva, Elisabetta Lambertini, Luisa Ferrari, Dorien J. Peters, Francesco Lanza, Peter C Harris, Pier Andrea Borea, Stefan Somlo, Laura Del Senno

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Polycystin-2 (PC2), encoded by the PKD2 gene, mutated in 10-15% of autosomal-dominant polycystic kidney disease (ADPKD) patients, is a Ca2+-permeable cation channel present in kidney epithelia and other tissues. As PC2 was found expressed in B-lymphoblastoid cells (LCLs) and Ca2+ signaling pathways are important regulators of B cell function activities, we investigated whether PC2 plays some role in B-LCLs. In LCLs, PC2 was found mainly in ER membranes but ~8 times less than in kidney HEK293 cells. The same reductions were found in PKD2 and PKD1 RNA; thus, PKD genes maintained, in LCLs, the same reciprocal proportion as they do in kidney cells. In LCLs obtained from subjects carrying PKD2 mutations (PKD2-LCLs) and showing reduced PC2 levels, intracellular Ca2+ concentrations evoked by platelet-activating factor (PAF), were significantly lower than in non-PKD-LCLs. This reduction was also found in PKD1-LCLs but without PC2 reductions. Likewise, cell proliferation, which is controlled by Ca2+, was reduced in PKD2- and PKD1-LCLs. Moreover, in LCLs with PKD2 nonsense mutations, aminoglycoside antibiotics reduced the PC2 defect by promoting readthrough of stop codons. Therefore, PC2 and PC1 are functionally expressed in LCLs, which provide a model, easily obtainable from ADPKD patients, to study PKD gene expression and function.

Original languageEnglish (US)
Pages (from-to)884-886
Number of pages3
JournalThe FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Volume18
Issue number7
StatePublished - 2004
Externally publishedYes

Fingerprint

Autosomal Dominant Polycystic Kidney
Cell proliferation
Cell Proliferation
Genes
Kidney
polycystic kidney disease 2 protein
Platelet Activating Factor
Aminoglycosides
Gene expression
Cations
Terminator Codon
Nonsense Codon
HEK293 Cells
Cells
RNA
Tissue
Anti-Bacterial Agents
Membranes
Defects
B-Lymphocytes

Cite this

Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. / Aguiari, Gianluca; Banzi, Manuela; Gessi, Stefania; Cai, Yiqiang; Zeggio, Emanuela; Manzati, Elisa; Piva, Roberta; Lambertini, Elisabetta; Ferrari, Luisa; Peters, Dorien J.; Lanza, Francesco; Harris, Peter C; Borea, Pier Andrea; Somlo, Stefan; Del Senno, Laura.

In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, No. 7, 2004, p. 884-886.

Research output: Contribution to journalArticle

Aguiari, G, Banzi, M, Gessi, S, Cai, Y, Zeggio, E, Manzati, E, Piva, R, Lambertini, E, Ferrari, L, Peters, DJ, Lanza, F, Harris, PC, Borea, PA, Somlo, S & Del Senno, L 2004, 'Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.', The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 18, no. 7, pp. 884-886.
Aguiari, Gianluca ; Banzi, Manuela ; Gessi, Stefania ; Cai, Yiqiang ; Zeggio, Emanuela ; Manzati, Elisa ; Piva, Roberta ; Lambertini, Elisabetta ; Ferrari, Luisa ; Peters, Dorien J. ; Lanza, Francesco ; Harris, Peter C ; Borea, Pier Andrea ; Somlo, Stefan ; Del Senno, Laura. / Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2004 ; Vol. 18, No. 7. pp. 884-886.
@article{1924011046294e2881fabf985fdb4dff,
title = "Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.",
abstract = "Polycystin-2 (PC2), encoded by the PKD2 gene, mutated in 10-15{\%} of autosomal-dominant polycystic kidney disease (ADPKD) patients, is a Ca2+-permeable cation channel present in kidney epithelia and other tissues. As PC2 was found expressed in B-lymphoblastoid cells (LCLs) and Ca2+ signaling pathways are important regulators of B cell function activities, we investigated whether PC2 plays some role in B-LCLs. In LCLs, PC2 was found mainly in ER membranes but ~8 times less than in kidney HEK293 cells. The same reductions were found in PKD2 and PKD1 RNA; thus, PKD genes maintained, in LCLs, the same reciprocal proportion as they do in kidney cells. In LCLs obtained from subjects carrying PKD2 mutations (PKD2-LCLs) and showing reduced PC2 levels, intracellular Ca2+ concentrations evoked by platelet-activating factor (PAF), were significantly lower than in non-PKD-LCLs. This reduction was also found in PKD1-LCLs but without PC2 reductions. Likewise, cell proliferation, which is controlled by Ca2+, was reduced in PKD2- and PKD1-LCLs. Moreover, in LCLs with PKD2 nonsense mutations, aminoglycoside antibiotics reduced the PC2 defect by promoting readthrough of stop codons. Therefore, PC2 and PC1 are functionally expressed in LCLs, which provide a model, easily obtainable from ADPKD patients, to study PKD gene expression and function.",
author = "Gianluca Aguiari and Manuela Banzi and Stefania Gessi and Yiqiang Cai and Emanuela Zeggio and Elisa Manzati and Roberta Piva and Elisabetta Lambertini and Luisa Ferrari and Peters, {Dorien J.} and Francesco Lanza and Harris, {Peter C} and Borea, {Pier Andrea} and Stefan Somlo and {Del Senno}, Laura",
year = "2004",
language = "English (US)",
volume = "18",
pages = "884--886",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "7",

}

TY - JOUR

T1 - Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.

AU - Aguiari, Gianluca

AU - Banzi, Manuela

AU - Gessi, Stefania

AU - Cai, Yiqiang

AU - Zeggio, Emanuela

AU - Manzati, Elisa

AU - Piva, Roberta

AU - Lambertini, Elisabetta

AU - Ferrari, Luisa

AU - Peters, Dorien J.

AU - Lanza, Francesco

AU - Harris, Peter C

AU - Borea, Pier Andrea

AU - Somlo, Stefan

AU - Del Senno, Laura

PY - 2004

Y1 - 2004

N2 - Polycystin-2 (PC2), encoded by the PKD2 gene, mutated in 10-15% of autosomal-dominant polycystic kidney disease (ADPKD) patients, is a Ca2+-permeable cation channel present in kidney epithelia and other tissues. As PC2 was found expressed in B-lymphoblastoid cells (LCLs) and Ca2+ signaling pathways are important regulators of B cell function activities, we investigated whether PC2 plays some role in B-LCLs. In LCLs, PC2 was found mainly in ER membranes but ~8 times less than in kidney HEK293 cells. The same reductions were found in PKD2 and PKD1 RNA; thus, PKD genes maintained, in LCLs, the same reciprocal proportion as they do in kidney cells. In LCLs obtained from subjects carrying PKD2 mutations (PKD2-LCLs) and showing reduced PC2 levels, intracellular Ca2+ concentrations evoked by platelet-activating factor (PAF), were significantly lower than in non-PKD-LCLs. This reduction was also found in PKD1-LCLs but without PC2 reductions. Likewise, cell proliferation, which is controlled by Ca2+, was reduced in PKD2- and PKD1-LCLs. Moreover, in LCLs with PKD2 nonsense mutations, aminoglycoside antibiotics reduced the PC2 defect by promoting readthrough of stop codons. Therefore, PC2 and PC1 are functionally expressed in LCLs, which provide a model, easily obtainable from ADPKD patients, to study PKD gene expression and function.

AB - Polycystin-2 (PC2), encoded by the PKD2 gene, mutated in 10-15% of autosomal-dominant polycystic kidney disease (ADPKD) patients, is a Ca2+-permeable cation channel present in kidney epithelia and other tissues. As PC2 was found expressed in B-lymphoblastoid cells (LCLs) and Ca2+ signaling pathways are important regulators of B cell function activities, we investigated whether PC2 plays some role in B-LCLs. In LCLs, PC2 was found mainly in ER membranes but ~8 times less than in kidney HEK293 cells. The same reductions were found in PKD2 and PKD1 RNA; thus, PKD genes maintained, in LCLs, the same reciprocal proportion as they do in kidney cells. In LCLs obtained from subjects carrying PKD2 mutations (PKD2-LCLs) and showing reduced PC2 levels, intracellular Ca2+ concentrations evoked by platelet-activating factor (PAF), were significantly lower than in non-PKD-LCLs. This reduction was also found in PKD1-LCLs but without PC2 reductions. Likewise, cell proliferation, which is controlled by Ca2+, was reduced in PKD2- and PKD1-LCLs. Moreover, in LCLs with PKD2 nonsense mutations, aminoglycoside antibiotics reduced the PC2 defect by promoting readthrough of stop codons. Therefore, PC2 and PC1 are functionally expressed in LCLs, which provide a model, easily obtainable from ADPKD patients, to study PKD gene expression and function.

UR - http://www.scopus.com/inward/record.url?scp=4644277547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644277547&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 884

EP - 886

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 7

ER -